Accure Therapeutics

A new medicine R&D engine (R&D pharma company) operated by an experienced team dedicated to the discovery and development of new medicines to treat patient suffering from severe diseases of the central nervous system. Accure Therapeutics focuses on neurons that suffer a dysfunction, and on the glial environment that supports them, in an attempt to impede their degeneration and death. We work to find new medicines that correct the pathological changes that are responsible for the disease, and that produce beneficial outcomes (i.e. Disease Modifying Therapies). We specialize in developing drugs that promote neuroprotection and neurorepair by integrating the latest...

Neuroprotection,multiple sclerosis,optic neuritis,parkinson,epilepsy,neurology,neurobiology ,cns diseases,pharmaceutical industry,remyelination,rare diseases,and neuromyelitis optica

Accure therapeutics operates in the Biotechnology research industry.

Accure therapeutics's revenue is 11m - 100m

Accure therapeutics has 11 - 50 employees.